Pager stock

Pager Stock

HealthTech
Founded: 2014Funding to Date: $177Mhttps://www.pager.com

Pager is a virtual care platform designed to provide improved tools and access to advocacy-based healthcare and support services. Its platform unites clinical and service teams, tools, services, and data into a single collaborative interface. Featuring a simple and intuitive messaging system, it includes triage nurses to direct members to the most convenient and cost-effective care options. It also connects users with providers through video consultations or scheduled visits with primary care doctors and specialists. This enables the healthcare industry to interact easily with their care teams and receive proper guidance.

Investors Include:

Carl Byers, Sound Ventures, Envision Healthcare, Ullas Naik, Susquehanna Private Equity Investments, French Partners, Peter McTeague, Fine Day Ventures, Goodwater Capital, Horizon Healthcare, Rani Aliahmad, Montage Ventures, Streamlined Ventures, Horizon Blue Cross Blue Shield of New Jersey, Haas Portman, Adam Goulburn, New Enterprise Associates, GuideWell, Michael Liou, Veronorte, QueensBridge Venture Partners, Three Fields Capital, Abundance Partners, Health Catalyst Capital Management, Lux Capital.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Management Team

Matthew KemplerChief Financial Officer
Walter JinChief Executive Officer, Chairman and President
Douglas BlackwellAdvisor
Dave DookeeramChief Operating Officer
Moses DodoAdvisory Board
Cammie BlaisChief People Officer
Peter LicursiChief Growth Officer
Steven ShiChief Technology Officer
Gaspard de DreuzyCo-Founder, Board Member & President
Oscar Salazar Ph.DCo-Founder
Rita SharmaChief Product Officer
Richard Boxer MDMedical Advisor
Sameer KhannaAdvisor

Board Members

Mohamad MakhzoumiBoard Member
Todd KimmelBoard Member
Eric KimBoard Member
Adam Goulburn Ph.DBoard Member
Charles BooradyBoard Member

Pager’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Centivo stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Egenesis stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
FogPharma stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Paradigm stock
Paradromics stock
Pathalys Pharma stock
Pelago stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
Sionna stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock

Companies backed by the same VC's

Assembled stock
Automation Anywhere stock
Beyond Identity stock
Built Robotics stock
Databricks stock
Expel stock
Guideline stock
Kong stock
Mashgin stock
Merge stock
Metronome stock
Narmi stock
Outrider stock
Pulumi stock
Sentry stock
SingleStore stock
Syllable stock
Theorycraft stock
Together stock